Minna Tanner
Impact in
- Hematology top 0.5%
- Blood groups and transfusion
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
Papers in
- Physiology 110
- Erythrocyte Function and Pathophysiology 105
- Hematology 29
- Blood groups and transfusion 29
- Co-authors
- Jorma IsolaDavid J. AnsteeOlli KallioniemiRitva KarhuAnne KallioniemiTapio VisakorpiÅke BorgAnita I. Kapanen
- Journals
- Biochemical Journal (34 papers)Blood (12 papers)Journal of Biological Chemistry (10 papers)Genes Chromosomes and Cancer (8 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- United KingdomFinlandUnited States
In The Last Decade
Minna Tanner
238 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Hematology 1.9k
- Oncology 4.6k
- Cancer Research 2.5k
- Physiology 4.1k
- Molecular Biology 7.1k
Countries citing papers authored by Minna Tanner
This map shows the geographic impact of Minna Tanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Tanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Tanner more than expected).
Fields of papers citing papers by Minna Tanner
This network shows the impact of papers produced by Minna Tanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Tanner. The network helps show where Minna Tanner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Minna Tanner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2023 | 13 | |
| 3 | 2022 | 1 | |
| 4 | 2018 | 76 | |
| 5 | 2018 | 164 | |
| 6 | 2016 | 7 | |
| 7 | 2016 | 25 | |
| 8 | 2014 | 14 | |
| 9 | 2013 | 1 | |
| 10 | 2012 | 3 | |
| 11 | 2010 | 90 | |
| 12 | 2009 | 2 | |
| 13 | 2005 | 159 | |
| 14 | 2004 | 214 | |
| 15 | HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil. | 2002 | 216 |
| 16 | 2002 | 69 | |
| 17 | Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer. | 2001 | 155 |
| 18 | 2001 | 110 | |
| 19 | [HER-2/neu oncogene in the selection of treatment for breast cancer and as a target of immunotherapy]. | 2000 | 1 |
| 20 | 1986 | 122 |
About Minna Tanner
Minna Tanner is a scholar working on Physiology, Hematology, Oncology, Cancer Research and Pediatrics, Perinatology and Child Health, having authored 243 papers that have together received 15.3k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (105 papers), Neonatal Health and Biochemistry (30 papers), HER2/EGFR in Cancer Research (30 papers), Blood groups and transfusion (29 papers), Lipid Membrane Structure and Behavior (26 papers), Pancreatic function and diabetes (25 papers), Glycosylation and Glycoproteins Research (24 papers) and Breast Cancer Treatment Studies (19 papers). The work is most often cited by research in Hematology (1.9k citations), Oncology (4.6k citations), Cancer Research (2.5k citations), Physiology (4.1k citations) and Molecular Biology (7.1k citations). Minna Tanner has collaborated with scholars based in United Kingdom, Finland and United States. Frequent co-authors include Jorma Isola, David J. Anstee, Olli Kallioniemi, Ritva Karhu, Anne Kallioniemi, Tapio Visakorpi, Åke Borg, Anita I. Kapanen, Jonathan D. Groves and K. Ridgwell. Their work appears in journals such as Biochemical Journal, Blood, Journal of Biological Chemistry, Genes Chromosomes and Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.